A., Cuthbertson
Department of Dentistry
CSL Behring
Austria
Biography
After completing medical training at the University of Melbourne and Ph.D in Immunology at the Walter and Eliza Hall Institute in Australia, Andrew Cuthbertson spent five years doing molecular biology research as a staff member at the Howard Florey Institute in Melbourne and the National Institutes of Health in the United States. He then spent seven years at Genentech Inc. in San Francisco, working on anti–VEGF therapy for age-related macular degeneration. Andrew was recruited to CSL Limited in 1997 and is the R&D Director and Chief Scientific Officer of CSL Limited.
Research Interest
Research, Pharmaceuticals, Biotechnology, Healthcare, Medical Science
